Literature DB >> 19954950

High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.

Hyun Ju Kim1, Jun Yuan, Keith Norris, Nosratola D Vaziri.   

Abstract

Chronic renal failure (CRF) is associated with malnutrition and renal tissue accumulation of lipids, which can contribute to progression of renal disease. This study was designed to explore the effect of a high-calorie diet on pathways involved in lipid metabolism in the remnant kidney of rats with CRF. 5/6 nephrectomized rats were randomized to receive a regular diet (3.0 kcal/g) or a high-calorie diet (4.5 kcal/g) for 12 weeks. Renal lipid contents and abundance of molecules involved in cholesterol and fatty acid metabolism were studied. The CRF group consuming a regular diet exhibited growth retardation; azotemia; proteinuria; glomerulosclerosis; tubulointerstitial injury; heavy lipid accumulation in the remnant kidney; up-regulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), ATP-binding cassette transporter-1 (ABCA1), liver X receptor (LXR) α/β, carbohydrate-responsive element binding protein (ChREBP) and acyl-CoA carboxylase (ACC); and down-regulation of peroxisome proliferator-activated receptor-α (PPAR-α), carnitine palmitoyltransferase-1 (CPT1) and liver-type fatty acid binding protein (L-FABP). The high-calorie diet restored growth; reduced the severity of tubulointerstitial injury, proteinuria and azotemia; partially lowered renal tissue lipid contents; attenuated the up-regulation of mediators of lipid influx (LOX-1), lipid efflux (LXR-α/β and ABCA1) and fatty acid biosynthesis (ChREBP and ACC); and reversed the down-regulation of factors involved in fatty acid oxidation (PPAR-α, CPT1 and L-FABP). In conclusion, a high-calorie diet restores growth, improves renal function and structure, and lowers lipid burden in the remnant kidney. The latter is associated with and most likely due to reduction in lipid influx and enhancement of fatty acid oxidation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19954950      PMCID: PMC3206097          DOI: 10.1016/j.jnutbio.2009.08.006

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  66 in total

Review 1.  The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

Authors:  M S Brown; J L Goldstein
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

Review 2.  Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.

Authors:  O Barbier; I Pineda Torra; Y Duguay; C Blanquart; J-C Fruchart; C Glineur; B Staels
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

Review 3.  Robert H Herman Memorial Award in Clinical Nutrition Lecture, 1997. Mechanisms causing loss of lean body mass in kidney disease.

Authors:  W E Mitch
Journal:  Am J Clin Nutr       Date:  1998-03       Impact factor: 7.045

4.  Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats.

Authors:  H Sakurai; Y Hisada; M Ueno; M Sugiura; K Kawashima; T Sugita
Journal:  Biochim Biophys Acta       Date:  1996-06-07

Review 5.  Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.

Authors:  Y Guan; M D Breyer
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

Review 6.  McCollum Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients.

Authors:  J D Kopple
Journal:  Am J Clin Nutr       Date:  1997-05       Impact factor: 7.045

7.  Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus.

Authors:  Lijun Sun; Nabil Halaihel; Weiping Zhang; Thomas Rogers; Moshe Levi
Journal:  J Biol Chem       Date:  2002-03-01       Impact factor: 5.157

8.  Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure.

Authors:  Yusaku Mori; Tsutomu Hirano; Masaharu Nagashima; Yuji Shiraishi; Tomoyasu Fukui; Mitsuru Adachi
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

9.  Involvement of glomerular SREBP-1c in diabetic nephropathy.

Authors:  Naomi Ishigaki; Takashi Yamamoto; Yoshio Shimizu; Kazuto Kobayashi; Shigeru Yatoh; Hirohito Sone; Akimitsu Takahashi; Hiroaki Suzuki; Kunihiro Yamagata; Nobuhiro Yamada; Hitoshi Shimano
Journal:  Biochem Biophys Res Commun       Date:  2007-10-16       Impact factor: 3.575

10.  Inadequate energy and excess protein intakes may be associated with worsening renal function in chronic kidney disease.

Authors:  Meng-Chuan Huang; Mei-En Chen; Hsin-Chia Hung; Hung-Chun Chen; Wen-Tsan Chang; Chien-Hung Lee; Yueh-Ying Wu; Hung-Che Chiang; Shang-Jyh Hwang
Journal:  J Ren Nutr       Date:  2008-03       Impact factor: 3.655

View more
  3 in total

1.  Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation.

Authors:  Nazanin Noori; Csaba P Kovesdy; Ramanath Dukkipati; Usama Feroze; Miklos Z Molnar; Rachelle Bross; Allen R Nissenson; Joel D Kopple; Keith C Norris; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2011-02-04       Impact factor: 3.754

2.  High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.

Authors:  Hyun Ju Kim; Nosratola D Vaziri; Keith Norris; Won Suk An; Yasmir Quiroz; Bernardo Rodriguez-Iturbe
Journal:  Clin Exp Nephrol       Date:  2010-09-07       Impact factor: 2.801

3.  High-Fructose Diet Increases Renal ChREBPβ Expression, Leading to Intrarenal Fat Accumulation in a Rat Model with Metabolic Syndrome.

Authors:  Ariel Bier; Eliyahu Shapira; Rawan Khasbab; Yehonatan Sharabi; Ehud Grossman; Avshalom Leibowitz
Journal:  Biology (Basel)       Date:  2022-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.